Galecto, Inc. (GLTO): Volume dana dhuwit perusahaan

Simbol lan logo merek Galecto Corp (GLTO)

Galecto, Inc. is developing a proprietary patent system of galectin inhibitors, focusing on cancer and organ fibrosis therapies. The company is currently prioritizing organic asset growth and local partnerships, temporarily limiting large-scale transactions. Analyzing the cash balance on GURU.Markets, we see that 0.01 determines the current value of this metric, confirming the firm's liquidity level.

GLTO - Volume dana dhuwit perusahaan Galecto Corp ing rentang 04.07.2022 - 10.03.2026

Ringkesan rincian data analitis Galecto (GLTO)

- nilai saham lan prakiraan konsensus rega:
Analisis fundamental perusahaan:Galecto Corp GLTO
Produk merek galecto.com

This metric reflects the volume of liquid assets required to ensure the issuer's operational stability. By analyzing the cash balance chart, an investor assesses the business's margin of safety before the need to raise new capital arises. The metric aggregates cash and equivalents, determining the company's ability to fund current expenses. For Galecto, Inc. (GLTO), this is critical during the development of fibrosis inhibitors. The monopoly on biologics requires significant investment prior to commercialization.

Pesaing wigati

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|Rezolute - Gunggung dana dhuwit perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis perusahaan|Dhuwit awis perusahaan MBX Bio|Dhuwit awis perusahaan ALT|AARD: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SGMT|Dana dhuwit perusahaan BIOA (BioAge Labs)|Volume dana dhuwit perusahaan BMEA (Biomea Fusion Corp)|Sisa dhuwit perusahaan QNCX|GUTS - Dana dhuwit perusahaan|VTVT - Volume dana dhuwit perusahaan|Agape ATP Corp. (ATPC) - Dana dhuwit perusahaan|Pluri Inc (PLUR) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Synlogic|Dana dhuwit perusahaan LPCN|Dana dhuwit perusahaan Matinas BioPharma Holdings, Inc. (MTNB)|Spruce Biosciences - Dhuwit awis lan setara dhuwit awis perusahaan|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)